While targeted protein and RNA degradation are hot areas for R&D, the drugs developed so far come with limitations. Now, a new class with broader applications may not be far off. In a study published ...

Osaka, Japan – Just as a recipe contains the instructions needed to make a dish, messenger ribonucleic acid (mRNA) sequences in the body contain the information needed to make proteins. Changes in the ...

A recent Pharmacological Reports study describes current approaches to managing the coronavirus disease 2019 (COVID-19), including diagnostic, therapeutic, and preventive measures. The severe acute ...

A new set of strategies is being investigated to combat the coronavirus disease 2019 (COVID-19), as well as other future viral pandemics. This includes the use of novel antigens, adjuvants, and ...

Pfizer's mRNA flu vaccine worked better than a standard flu shot in a large Phase 3 trial, researchers reported in the ...

Scientists have discovered a surprising silver lining of COVID-19 infection. A new study by researchers at Northwestern Medicine Canning Thoracic Institute, published in the Journal of Clinical ...

MINNEAPOLIS -- According to the Metropolitan Council, the amount of COVID-19 RNA found in the metro's wastewater is decreasing. This is in contrast to last week, which saw a 36% increase in the amount ...

Arbutus Biopharma has become the latest biotech to exit the COVID-19 space as well as discontinuing its work on RNA destabilizers, tightening its focus on hepatitis B. The company’s pipeline had ...

mRNA vaccines can enhance immunotherapy efficacy by activating the immune system, improving outcomes in hard-to-treat tumors. mRNA COVID-19 vaccines enhance immune responses, improving cancer ...